Catalyst Capital Advisors’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.2K Sell
89
-25
-22% -$3.14K ﹤0.01% 448
2025
Q1
$15.6K Hold
114
﹤0.01% 414
2024
Q4
$17.4K Sell
114
-485
-81% -$74.2K ﹤0.01% 446
2024
Q3
$116K Buy
599
+457
+322% +$88.6K ﹤0.01% 262
2024
Q2
$32.9K Buy
142
+4
+3% +$927 ﹤0.01% 278
2024
Q1
$29.8K Buy
+138
New +$29.8K ﹤0.01% 285
2023
Q4
Sell
-107
Closed -$27.5K 380
2023
Q3
$27.5K Buy
107
+27
+34% +$6.94K ﹤0.01% 290
2023
Q2
$22.8K Sell
80
-4
-5% -$1.14K ﹤0.01% 304
2023
Q1
$23.4K Sell
84
-28
-25% -$7.79K ﹤0.01% 288
2022
Q4
$31K Sell
112
-4
-3% -$1.11K ﹤0.01% 275
2022
Q3
$31K Sell
116
-1
-0.9% -$267 ﹤0.01% 286
2022
Q2
$24K Buy
117
+16
+16% +$3.28K ﹤0.01% 311
2022
Q1
$21K Buy
101
+19
+23% +$3.95K ﹤0.01% 375
2021
Q4
$20K Sell
82
-8
-9% -$1.95K ﹤0.01% 357
2021
Q3
$25K Sell
90
-3
-3% -$833 ﹤0.01% 328
2021
Q2
$32K Buy
93
+3
+3% +$1.03K ﹤0.01% 332
2021
Q1
$25K Sell
90
-638
-88% -$177K ﹤0.01% 308
2020
Q4
$178K Sell
728
-362
-33% -$88.5K 0.01% 240
2020
Q3
$309K Sell
1,090
-195
-15% -$55.3K 0.02% 199
2020
Q2
$344K Hold
1,285
0.02% 202
2020
Q1
$407K Sell
1,285
-265
-17% -$83.9K 0.02% 154
2019
Q4
$460K Buy
+1,550
New +$460K 0.01% 192
2019
Q2
Sell
-3,750
Closed -$886K 418
2019
Q1
$886K Buy
+3,750
New +$886K 0.03% 134
2018
Q4
Sell
-2,100
Closed -$742K 421
2018
Q3
$742K Buy
+2,100
New +$742K 0.02% 193
2016
Q4
Sell
-353
Closed -$111K 384
2016
Q3
$111K Sell
353
-11,050
-97% -$3.47M 0.01% 266
2016
Q2
$2.76M Sell
11,403
-16,520
-59% -$3.99M 0.51% 73
2016
Q1
$7.27M Sell
27,923
-239
-0.8% -$62.2K 1.22% 23
2015
Q4
$8.63M Buy
28,162
+27,615
+5,048% +$8.46M 1.25% 16
2015
Q3
$160K Buy
547
+447
+447% +$131K 0.02% 261
2015
Q2
$40K Hold
100
﹤0.01% 333
2015
Q1
$42K Hold
100
﹤0.01% 339
2014
Q4
$34K Buy
+100
New +$34K ﹤0.01% 353
2014
Q2
Sell
-212
Closed -$65K 341
2014
Q1
$65K Buy
+212
New +$65K 0.01% 295